| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.081 | 0.07 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.08 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |